PharmaCann International
Grow Group UK
About French Cookies
FCHybridThis strain boasts a highly unique palette of colors ranging from light green and yellow to deep purple.
American Bred
French Cookies is a hybrid strain that produces dense flowers that are high in resin production and feature bright orange calyxes. This strain boasts a highly unique palette of colors ranging from light green and yellow to deep purple. She offers a pleasant high that can be described as happy, focused, relaxed, and creative—traits that make French Cookies a great daytime smoke when getting things done. These effects are augmented by tastes of cookies, earth, and sweetness.
Description provided by CannaConnection.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About PhCann International B.V.
PharmaCann International is a leading company in the field of pharmaceutical cannabis, operating in accordance with EU GMP standards, with vertically integrated operations including, cloning, cultivating, cannabinoid API extraction, and pharmaceutical production and packaging.
Since inception, PharmaCann International has strive in its corporate social responsibility strategy to provide patients in need of products containing high-quality cannabinoids of natural origin and to disseminate knowledge about the therapeutic use of cannabinoids.
PharmaCann’s mission is make available a wide range of medical cannabis preparations for patients, who can benefit clinically, at the right time, at the right cost and for the right indication. Quality Control
PharmaCann operates in accordance with the highest standards, including GACP, GLP, GDP and ISO 9001, ISO 14001, ISO 27001 ISO 17025. and has a world-class laboratory for testing cannabinoids and research and development.
The Company’s European pharmaceutical cannabis facility has incorporated the latest growing, extraction and packaging technology as well established scientific methodologies to develop targeted medical cannabis products.
nyskholdings.com
Further National Health-Service Information on